Marvel Biosciences Selected to Present Alzheimer's Research at the 2025 Alzheimer's Association International Conference @marvelbiotechnology #Chemicals #Biotechnology #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing
Calgary, Alberta--(Newsfile Corp. - April 14, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively "Marvel" or the "Company"), is pleased to announce that it has been invited to present its latest research findings at the Alzheimer's Association International Conference (AAIC), taking place in July 2025.The Company will present preclinical data from its acute Alzheimer's disease study, conducted in collaboration...
http://dlvr.it/TK8BH7
http://dlvr.it/TK8BH7
Comments
Post a Comment